We are.
I think it gets under-reported and is not discussed enough. We're a small country so the numbers are never going to be the same as they are in the United States, just because of the numbers of medical students and faculties. We have emerging researchers, young and mid-career researchers, who are embarking on new, for them, relationships with industry. If you talk to the colleagues at Rx & D, BIOTECanada, and MEDEC, they'll tell you that one of the big barriers is that we've got some legislative hurdles that federally we need to fix in order to make innovation more possible and commercialization a little bit easier. We hear all the time, though, that in terms of R and D the federal government is investing quite a bit and it's the private sector that isn't stepping up to the plate enough. Their response to us has been that it has a lot to do with the legislative environment.
There are, particularly for those students who are interested in creating a research career for themselves, many more mentors than there used to be and many more folks who are encouraging that type of interaction.